GLOW70

GLOW70 is a research-focused peptide blend, also referred to as the Glow Protocol Peptide Blend. It combines three well-studied peptides — GHK-Cu, TB500, and BPC-157 — each of which is being investigated for its unique biological pathways and potential role in regenerative and metabolic research.

Peptides in the GLOW70 Blend:

• GHK-Cu (50 mg): A copper-binding peptide that has been studied for its role in collagen-related pathways, angiogenesis, and antioxidant activity. Researchers are exploring its relevance to skin and tissue health.

• TB500 (10 mg): Investigated for its effects on actin polymerization, which may influence cell migration and tissue-related processes. It is commonly referenced in studies of recovery and regeneration models.

• BPC-157 (10 mg): A peptide of interest in studies related to growth factor activity, angiogenesis, and collagen dynamics. Research has also examined its role in gastrointestinal and tissue support models.

Areas of Research Interest:

• Cellular and Tissue Studies: Exploration of how these peptides may influence cellular proliferation, migration, and signaling.

• Metabolic and Regenerative Pathways: Ongoing research into how peptide combinations may interact with systems linked to repair and optimization.

• Inflammation Models: Investigated for potential roles in studies examining inflammatory responses.

• Skin and Connective Tissue Research: GHK-Cu and related peptides are often studied in connection with collagen pathways and oxidative balance.

• Gut and Gastrointestinal Models: BPC-157 has drawn research interest in studies focused on gastrointestinal tissue integrity.